GlassScriptPhysician profile
Brent Bevard
NPI 1669486692
$6,140.04
in general payments reported to CMS, 2019-2025
23 companies · $619 in 2025
The $619 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $385 · 2021: $297 · 2022: $330 · 2023: $2,298 · 2024: $515 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Travel and Lodging: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,200.03 |
| Travel and Lodging | $1,232.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,084.07 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $493.60 | 2019-2025 | General - Therapies |
| Medtronic, INC. | $457.03 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $363.41 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $107.95 | 2023-2025 | Belbuca, Xtampza |
| Vertos Medical, INC. | $106.36 | 2020-2021 | |
| Medtronic USA, INC. | $87.96 | 2019 | |
| Idorsia Pharmaceuticals US INC | $69.49 | 2023 | Quviviq |
| Biotronik Nro, INC. | $62.55 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.99 | 2022-2025 | Relistor |
| Coloplast Corp | $35.26 | 2023-2024 | Porges Coloplast |
| Grt US Holding, INC. | $30.70 | 2022 | |
| Pfizer INC. | $27.96 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.46 | 2025 | Ultomiris |
| Nalu Medical, INC. | $19.69 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.14 | 2025 | |
| Valinor Pharma, LLC | $15.70 | 2025 | Movantik |
| Scilex Pharmaceuticals INC. | $15.43 | 2019 | |
| Spinal Simplicity, LLC | $15.38 | 2024 | Ha Minuteman G3-R |
| Pacira Therapeutics, INC. | $13.60 | 2019 | |
| Shionogi INC | $13.48 | 2019 | |
| Biodelivery Sciences International, INC. | $11.55 | 2019 | |
| Bioventus LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Bevard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.